Patrys Ltd
ASX:PAB
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Patrys Ltd
Patrys Ltd
Total Receivables
Patrys Ltd
Total Receivables Peer Comparison
MSB
CSL
CUV
TLX
PYC
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Patrys Ltd
ASX:PAB
|
Total Receivables
AU$654k
|
CAGR 3-Years
-6%
|
CAGR 5-Years
28%
|
CAGR 10-Years
29%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Total Receivables
$4m
|
CAGR 3-Years
6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Total Receivables
$3.6B
|
CAGR 3-Years
20%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Total Receivables
AU$13.1m
|
CAGR 3-Years
39%
|
CAGR 5-Years
66%
|
CAGR 10-Years
25%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Total Receivables
AU$71.9m
|
CAGR 3-Years
72%
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Total Receivables
AU$8.7m
|
CAGR 3-Years
344%
|
CAGR 5-Years
120%
|
CAGR 10-Years
14%
|
See Also
What is Patrys Ltd's Total Receivables?
Total Receivables
654k
AUD
Based on the financial report for Dec 31, 2023, Patrys Ltd's Total Receivables amounts to 654k AUD.
What is Patrys Ltd's Total Receivables growth rate?
Total Receivables CAGR 10Y
29%
Over the last year, the Total Receivables growth was -87%. The average annual Total Receivables growth rates for Patrys Ltd have been -6% over the past three years , 28% over the past five years , and 29% over the past ten years .
You don't have any saved screeners yet
